PT  - JOURNAL ARTICLE
AU  - Anosisye M. Kesale
AU  - Mikidadi Muhanga
AU  - Christopher Mahonge
TI  - The Governance of Pandemics in Primary Health Care: The Governance Strategies Adopted by Health Facility Governing Committees in Times of COVID Pandemic in Tanzania
AID  - 10.1101/2022.01.03.22268663
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.03.22268663
4099  - http://medrxiv.org/content/early/2022/01/06/2022.01.03.22268663.short
4100  - http://medrxiv.org/content/early/2022/01/06/2022.01.03.22268663.full
AB  - The governance of COVID 19 in Lower and Middle-Income Countries (LMICs) is very critical for curbing its effects. However, it is unknown what governance strategies are adopted by Health Facility Governing Committees (HFGCs) s as a response to the pandemic. We employed an exploratory qualitative design to study the governance strategies adopted by HFGCs during the COVID19. Since COVID 19 is new, an inductive approach was used as it involves analyzing collected data with little or no predetermined theory for the study. A purposive sampling technique was employed in which multistage clustered sampling was used to select regions, councils, health facilities and respondents. In-depth interviews with HFGCs chairpersons and Focus Group Discussions with members of HFGCs were used to collect data. The data were analyzed based on the themes which emerged during data collection. We found five governance strategies that were found to be commonly adopted by many HFGCs which are financial allocation, re-planing, mobilization of resources, community sensitization and mobilization of stakeholders. however, these governance structures were not all adopted by all HFGCs. The HFGCs slowly adopted governance strategies in the times of COVID 19 pandemics because were unprepared. Despite being empowered by the Direct Health Facility Financing, still, the newest of the COVID 19 has been a challenge to many HFGCs. This calls for urgent capacity building for governance institutions on how to deal will pandemics in primary health facilities.Key QuestionsWhat is Already Known?What is Already Known?➢ Governance of pandemics is very critical for minimizing its effects➢ Government in Lower and Middle-Income Countries (LMICs) reacted differently to bring the COVID 19 pandemic under control➢ Little is known on the governance strategies adopted by Health Facility Governing Committees (HFGCs) to control COVID 19 at the primary health care facilities in LMICsWhat are the new findings?What are the new findings?➢ HFGCs response to the COVID 19 is mixed as some HFGCs were so active and others were so slowly in instituting governance strategies to combat the pandemic➢ The common governance strategies adopted were financial allocation, re-planning, embolization of resources, community sensitization and stakeholders mobilization➢ HFGCs in LMICs were not well prepared for the pandemic at the community levelWhat do new findings imply?What do new findings imply?➢ Capacitated HFGCs in both soft and hard aspects cornerstone for effective governance of the pandemics in primary health care➢ Preparedness of pandemics in LMICs needs to go beyond upper-level governance structuresCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical Committee National Institute of Medical Research (NIMR)- (Ref.No.NIMR/HQ/R.8a/Vol.IX/2740.)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript